Sökning: WFRF:(Sander C)
> Doktorsavhandling >
Model-Based Optimiz...
Model-Based Optimization of Clinical Trial Designs
-
- Vong, Camille (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Pharmacometrics Research Group
-
- Karlsson, Mats O. (preses)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Hooker, Andrew C. (preses)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
visa fler...
-
- Friberg, Lena E. (preses)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Chenel, Marylore (preses)
- Institut de Recherches Internationales Servier, Suresnes, France
-
- Sander, Oliver, PhD (opponent)
- Novartis AG, Basel, Switzerland
-
visa färre...
-
(creator_code:org_t)
- ISBN 9789155490638
- Uppsala : Acta Universitatis Upsaliensis, 2014
- Engelska 124 s.
-
Serie: Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, 1651-6192 ; 192
- Relaterad länk:
-
https://uu.diva-port... (primary) (Raw object)
-
visa fler...
-
https://uu.diva-port... (Preview)
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- General attrition rates in drug development pipeline have been recognized as a necessity to shift gears towards new methodologies that allow earlier and correct decisions, and the optimal use of all information accrued throughout the process. The quantitative science of pharmacometrics using pharmacokinetic-pharmacodynamic models was identified as one of the strategies core to this renaissance. Coupled with Optimal Design (OD), they constitute together an attractive toolkit to usher more rapidly and successfully new agents to marketing approval.The general aim of this thesis was to investigate how the use of novel pharmacometric methodologies can improve the design and analysis of clinical trials within drug development. The implementation of a Monte-Carlo Mapped power method permitted to rapidly generate multiple hypotheses and to adequately compute the corresponding sample size within 1% of the time usually necessary in more traditional model-based power assessment. Allowing statistical inference across all data available and the integration of mechanistic interpretation of the models, the performance of this new methodology in proof-of-concept and dose-finding trials highlighted the possibility to reduce drastically the number of healthy volunteers and patients exposed to experimental drugs. This thesis furthermore addressed the benefits of OD in planning trials with bio analytical limits and toxicity constraints, through the development of novel optimality criteria that foremost pinpoint information and safety aspects. The use of these methodologies showed better estimation properties and robustness for the ensuing data analysis and reduced the number of patients exposed to severe toxicity by 7-fold. Finally, predictive tools for maximum tolerated dose selection in Phase I oncology trials were explored for a combination therapy characterized by main dose-limiting hematological toxicity. In this example, Bayesian and model-based approaches provided the incentive to a paradigm change away from the traditional rule-based “3+3” design algorithm.Throughout this thesis several examples have shown the possibility of streamlining clinical trials with more model-based design and analysis supports. Ultimately, efficient use of the data can elevate the probability of a successful trial and increase paramount ethical conduct.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Nyckelord
- nonlinear mixed-effects models
- pharmacometrics
- likelihood ratio test
- NONMEM
- power
- sample size
- study design
- proof-of-concept
- dose-finding
- population optimal design
- LOQ
- BQL data
- neutropenia
- docetaxel
- myelosuppression
- thrombocytopenia
- MTD
- Bayesian methods
- 3+3 algorithm
- dose escalation study
- Pharmaceutical Science
- Farmaceutisk vetenskap
Publikations- och innehållstyp
- vet (ämneskategori)
- dok (ämneskategori)
Hitta via bibliotek
Till lärosätets databas